Literature DB >> 2866945

Therapeutic use of respiratory stimulants. An overview of newer developments.

B M Galko, A S Rebuck.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2866945     DOI: 10.2165/00003495-198530060-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  40 in total

1.  The effects of the carbonic anhydrase inhibitor 6063 on electrolytes and acid-base balance in two normal subjects and two patients with respiratory acidosis.

Authors:  J NADELL
Journal:  J Clin Invest       Date:  1953-07       Impact factor: 14.808

2.  Progesterone therapy in obese patients with sleep apnea.

Authors:  W C Orr; N K Imes; R J Martin
Journal:  Arch Intern Med       Date:  1979-01

3.  Therapeutic use of progesterone in alveolar hypoventilation associated with obesity.

Authors:  H A Lyons; C T Huang
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

4.  [Ventilatory effects in healthy men of a new analeptic drug, S 2620 (author's transl)].

Authors:  R Guillerm; E Radziszewski
Journal:  Bull Physiopathol Respir (Nancy)       Date:  1974 Nov-Dec

5.  Clinical pharmacology of almitrine bismesylate.

Authors:  R Pariente
Journal:  Eur J Respir Dis Suppl       Date:  1983

6.  Aminophylline and its influence on ventilatory endurance in humans.

Authors:  M J Belman; G C Sieck; A Mazar
Journal:  Am Rev Respir Dis       Date:  1985-02

7.  The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction.

Authors:  A C Powles; D V Tuxen; C B Mahood; S O Pugsley; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1983-03

8.  Effect of naloxone in a previously undescribed hypothalamic syndrome. A disorder of the endogenous opioid peptide system?

Authors:  D B Dunger; J V Leonard; O H Wolff; M A Preece
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

9.  Endogenous opiates and chemical control of breathing in humans.

Authors:  J A Fleetham; H Clarke; S Dhingra; V Chernick; N R Anthonisen
Journal:  Am Rev Respir Dis       Date:  1980-06

10.  [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].

Authors:  Y Castaing; G Manier; N Varène; H Guénard
Journal:  Bull Eur Physiopathol Respir       Date:  1981 Nov-Dec
View more
  1 in total

Review 1.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.